These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1151660)

  • 1. Soft gelatin capsules II: Oxygen permeability study of capsule shells.
    Hom FS; Veresh SA; Ebert WR
    J Pharm Sci; 1975 May; 64(5):851-7. PubMed ID: 1151660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
    Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatin and Non-Gelatin Capsule Dosage Forms.
    Gullapalli RP; Mazzitelli CL
    J Pharm Sci; 2017 Jun; 106(6):1453-1465. PubMed ID: 28209365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water migration from soft gelatin capsule shell to fill material and its effect on drug solubility.
    Serajuddin AT; Sheen PC; Augustine MA
    J Pharm Sci; 1986 Jan; 75(1):62-4. PubMed ID: 3958908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M; Rothenhäusler B; Röthlisberger D
    Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
    J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug migration into soft gelatin capsule shells and its effect on in-vitro availability.
    Armstrong NA; James KC; Pugh WK
    J Pharm Pharmacol; 1984 Jun; 36(6):361-5. PubMed ID: 6146665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional properties of dually modified sago starch/κ-carrageenan films: An alternative to gelatin in pharmaceutical capsules.
    Oladzadabbasabadi N; Ebadi S; Mohammadi Nafchi A; Karim AA; Kiahosseini SR
    Carbohydr Polym; 2017 Mar; 160():43-51. PubMed ID: 28115099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on gelatin capsule brittleness: moisture tranfer between the capsule shell and its content.
    Chang RK; Raghavan KS; Hussain MA
    J Pharm Sci; 1998 May; 87(5):556-8. PubMed ID: 9572904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells.
    Zhao F; Malayev V; Rao V; Hussain M
    Pharm Res; 2004 Jan; 21(1):144-8. PubMed ID: 14984269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules.
    Barham AS; Tewes F; Healy AM
    Int J Pharm; 2015 Jan; 478(2):796-803. PubMed ID: 25526672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of soft gelatin capsules by thermal analysis.
    Nazzal S; Wang Y
    Int J Pharm; 2001 Nov; 230(1-2):35-45. PubMed ID: 11672954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
    Likar MD; Carroll SC; Colgan ST; Yeoh T; MacDonald BC; Johnson GM; Space JS
    J Pharm Sci; 2018 Dec; 107(12):3080-3088. PubMed ID: 30145210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprinting on empty hard gelatin capsule shells containing titanium dioxide by application of the UV laser printing technique.
    Hosokawa A; Kato Y; Terada K
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1047-53. PubMed ID: 23786207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of bendrofluazide in a low-dose extemporaneously prepared capsule.
    Barnes AR; Nash S
    J Clin Pharm Ther; 1994 Apr; 19(2):89-93. PubMed ID: 8071398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of capsule size on permeability of gelatin-acacia microcapsules toward sodium chloride.
    Jalsenjak I; Kondo T
    J Pharm Sci; 1981 Apr; 70(4):456-7. PubMed ID: 7229967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in-vitro investigation of drug availability from lipophilic solutions.
    Armstrong NA; James KC; Pugh WK
    J Pharm Pharmacol; 1984 Jun; 36(6):357-60. PubMed ID: 6146664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shell Formulation in Soft Gelatin Capsules: Design and Characterization.
    Naharros-Molinero A; Caballo-González MÁ; de la Mata FJ; García-Gallego S
    Adv Healthc Mater; 2024 Jan; 13(1):e2302250. PubMed ID: 37775861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lipophilic components on the compatibility of lipid-based formulations with hard gelatin capsules.
    Chen FJ; Etzler FM; Ubben J; Birch A; Zhong L; Schwabe R; Dudhedia MS
    J Pharm Sci; 2010 Jan; 99(1):128-41. PubMed ID: 19455627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.